SCHEMBL3384808

SCHEMBL3384808

COc1ccc2c(OC)ccc(C(=O)Nc3ccc(-c4ccc5c(C(=O)O)n[nH]c5c4)cc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAA1 Q13131 4/20 0.53
PRKAG1 P54619 3/20 0.53
PRKAB1 Q9Y478 3/20 0.53
CDK2 P24941 2/20 0.48
FLT3 P36888 2/20 0.48
ROCK1 Q13464 1/20 0.48
DYRK3 O43781 1/20 0.46
MAP4K4 O95819 1/20 0.46
CDK1 P06493 1/20 0.46
MARK3 P27448 1/20 0.46
CLK2 P49760 1/20 0.46
GSK3B P49841 1/20 0.46
CSNK2A1 P68400 1/20 0.46
CSNK1G2 P78368 1/20 0.46
CDK5 Q00535 1/20 0.46
MAP4K2 Q12851 1/20 0.46
CAMK2B Q13554 1/20 0.46
CAMK2G Q13555 1/20 0.46
CAMK2D Q13557 1/20 0.46
DYRK1A Q13627 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385482 0.89 NPC1 (0.49) PRKAA1PRKAG1PRKAB1CDK2FLT3
SCHEMBL3382225 0.79 PRKAG1 (0.56) PRKAA1PRKAG1PRKAB1CDK2FLT3
SCHEMBL3380526 0.76 PRKAG1 (0.48) PRKAA1PRKAG1PRKAB1CDK2FLT3
SCHEMBL3386872 0.76 KDM4E (0.56) KDM4ELMNASMN1; SMN2MEN1KMT2A
SCHEMBL3383247 0.75 HPGD (0.53) PRKAA1PRKAG1PRKAB1CDK2FLT3
SCHEMBL176882 0.75 PRKAG1 (0.66) PRKAA1PRKAG1PRKAB1CDK2FLT3
SCHEMBL3380466 0.72 PAK1 (0.47) PRKAA1PRKAG1PRKAB1ROCK1CLK2
SCHEMBL3386831 0.71 NPC1 (0.54) PRKAA1PRKAG1PRKAB1FLT3NPC1
SCHEMBL4493778 0.70 HDAC6 (0.66) HDAC6FGFR4
SCHEMBL3386582 0.70 FLT3 (0.53) PRKAA1PRKAG1PRKAB1CDK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed